Iyengar Capital Partners

Sealonix is a company dedicated to the development and commercialization of innovative hemostatic sealants utilizing proprietary biomaterials. It specializes in creating a sealant patch designed to achieve rapid hemostasis during surgical procedures, specifically targeting abdominopelvic and orthopedic operations. The PramStat patch is engineered to bioabsorb within one week of implantation, offering a timely solution for surgeons and enhancing patient safety and recovery.

Rejoni, Inc. is a medical device company based in Bedford, Massachusetts, founded in 2020. It specializes in developing and commercializing innovative solutions aimed at enhancing the outcomes of gynecological surgical procedures. The company focuses on preventing scar formation after intrauterine interventions, addressing both acute and chronic risks associated with such procedures. By utilizing biomaterials, Rejoni creates gynecological products that prioritize women's health, enabling patients to achieve their desired quality of life both now and in the future.